Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
NurExone logo

NurExone

Recent Finacing

Equity

Recent Raise

$2.3M

NurExone Biologic develops exosome-based regenerative therapeutics, including its lead ExoPTEN program.

Hefa, Israel
11-50
Publicly Traded
nurexone.com

Highlights

Focus Areas

Biopharma
Biotechnology
Clinical Trials

Financials

$2.3M

Total Raised

1

Funding round


Team

Upgrade to view the team

See the team members at NurExone.